Five Prime Therapeutics' Partnership - V Round

Five Prime Therapeutics raised a round of funding on April 22, 2012. Investors include GlaxoSmithKline.

Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…

Articles about Five Prime Therapeutics' Partnership - V Round: